Pathological correlates of recurrence timing and post-recurrence survival after surgery for renal cell carcinoma in a multicenter cohort

Background We examined the associations of pathological findings with recurrence within 1 year after surgery for renal cell carcinoma and the association between recurrence timing and subsequent survival. Methods This retrospective study included 478 patients from seven Japanese centers: 467 without distant metastasis and 11 with resected metastatic disease recorded as no evidence of disease. Among recurrent patients, binary logistic regression compared recurrence at < 12 versus ≥ 12 months from renal surgery, adjusting for tumor size, grade, necrosis, lymphatic invasion, clinical T category, and pathological nodal status. Three-group analyses using a 6-month subdivision were exploratory. Kaplan–Meier analysis and Cox regression assessed post-recurrence overall survival. Results Recurrence occurred in 187 patients: 84 at < 12 months and 103 at ≥ 12 months. Tumor necrosis (adjusted odds ratio 2.40, 95% confidence interval 1.24–4.72; P = 0.0099) and lymphatic invasion (3.12, 1.38–7.42; P = 0.0077) were associated with recurrence at < 12 months. Among recurrent patients, 86 died. Median post-recurrence survival was 50.6 versus 82.0 months for recurrence at < 12 versus ≥ 12 months. The mortality hazard ratio adjusted for age and necrosis was 1.81 (95% confidence interval 1.15–2.84; P = 0.0098). Conclusions Among patients who recurred, tumor necrosis and lymphatic invasion were associated with recurrence within 1 year, which was associated with poorer subsequent survival. These exploratory findings require external validation before informing clinical management.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11682255/v1
Primary Topic
Renal cell carcinoma treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pathological correlates of recurrence timing and post-recurrence survival after surgery for renal cell carcinoma in a multicenter cohort

Ken Kawada, Kazuyuki Numakura, Tomokazu Sazuka, Sei Naito et al.
1 links
Research Square
Renal cell carcinoma treatment
preprint

Pathological correlates of recurrence timing and post-recurrence survival after surgery for renal cell carcinoma in a multicenter cohort

Ken Kawada, Kazuyuki Numakura, Tomokazu Sazuka, Sei Naito, Yu Kujiraoka, Haruka Miyata, Ryoichi Imamura, Kojiro Ohba, Keita Minami, Yuya Sekine, Keisuke Ando, Masaharu Oki, Tsuyoshi Matsuda, Norihiko Tsuchiya, Toru Harabayashi
preprint en

Abstract

Background We examined the associations of pathological findings with recurrence within 1 year after surgery for renal cell carcinoma and the association between recurrence timing and subsequent survival. Methods This retrospective study included 478 patients from seven Japanese centers: 467 without distant metastasis and 11 with resected metastatic disease recorded as no evidence of disease. Among recurrent patients, binary logistic regression compared recurrence at < 12 versus ≥ 12 months from renal surgery, adjusting for tumor size, grade, necrosis, lymphatic invasion, clinical T category, and pathological nodal status. Three-group analyses using a 6-month subdivision were exploratory. Kaplan–Meier analysis and Cox regression assessed post-recurrence overall survival. Results Recurrence occurred in 187 patients: 84 at < 12 months and 103 at ≥ 12 months. Tumor necrosis (adjusted odds ratio 2.40, 95% confidence interval 1.24–4.72; P = 0.0099) and lymphatic invasion (3.12, 1.38–7.42; P = 0.0077) were associated with recurrence at < 12 months. Among recurrent patients, 86 died. Median post-recurrence survival was 50.6 versus 82.0 months for recurrence at < 12 versus ≥ 12 months. The mortality hazard ratio adjusted for age and necrosis was 1.81 (95% confidence interval 1.15–2.84; P = 0.0098). Conclusions Among patients who recurred, tumor necrosis and lymphatic invasion were associated with recurrence within 1 year, which was associated with poorer subsequent survival. These exploratory findings require external validation before informing clinical management.

Research Square
Yamagata University (JP), Asahikawa Medical University (JP), Chiba University (JP), Akita University (JP), Hokkaido University (JP), Sapporo City General Hospital (JP), National Hospital Organization Hokkaido Cancer Center (JP), Nagasaki University (JP)
Good health and well-being
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon